Invasive Breast Carcinoma Clinical Trials

102 clinical trials for Invasive Breast Carcinoma across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neoadjuvant Breast Cancer Time Restricted Eating — RECRUITING · PHASE2
• Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer — RECRUITING · PHASE2
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection — RECRUITING
• A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer — RECRUITING · PHASE1
• Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer — RECRUITING · PHASE1
• Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer — RECRUITING · PHASE1
• Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy — RECRUITING · PHASE3
• Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer. — RECRUITING · NA
• Breast Cancer Survivorship Biorepository — RECRUITING
• Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer — RECRUITING
• Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery — RECRUITING
• Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — RECRUITING · NA
• Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer — RECRUITING
• Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer — RECRUITING
• Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy — RECRUITING · NA
• NearWave Optical Molecular Monitoring — RECRUITING · NA
• Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer — RECRUITING · NA
• Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC — RECRUITING · NA
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases — TERMINATED · PHASE1
• Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE3
• Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative — ACTIVE_NOT_RECRUITING · NA
• Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca — ACTIVE_NOT_RECRUITING · PHASE2
• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer — COMPLETED · PHASE2
• Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial — ACTIVE_NOT_RECRUITING · PHASE2
• Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial — ACTIVE_NOT_RECRUITING · PHASE3
• Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer — ACTIVE_NOT_RECRUITING
• Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy — ACTIVE_NOT_RECRUITING · PHASE2
• National Cancer Institute "Cancer Moonshot Biobank" — ACTIVE_NOT_RECRUITING
• Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France. — ACTIVE_NOT_RECRUITING
• Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer — COMPLETED · PHASE2
• Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Areola Preservation in NSM With Nipple Involvement — NOT_YET_RECRUITING · NA
• Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors — WITHDRAWN · PHASE1
• Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer — NOT_YET_RECRUITING
• Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer — COMPLETED · PHASE1
• Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search